Extensively Hydrolyzed Formula: Hypoallergenicity



Status:Completed
Conditions:Food Studies, Neurology
Therapuetic Areas:Neurology, Pharmacology / Toxicology
Healthy:No
Age Range:Any
Updated:9/23/2012
Start Date:February 2011
End Date:December 2012
Contact:Dan Schwartz
Email:dan.schwartz@rd.nestle.com
Phone:952-848-6486

Use our guide to learn which trials are right for you!

Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula


The primary objective of this clinical trial is to determine whether a new extensively
hydrolyzed infant formula is hypoallergenic.


Inclusion Criteria:

1. Born at term (>36 weeks gestation)

2. Two (2) months to ≤ 12 years of age at enrollment

3. Documented Cow's Milk Allergy (CMA) within the 6 months prior to enrollment by:

1. Reported convincing allergic symptoms following an exposure to milk or a
milk-containing food product and [detectable serum milk-specific IgE (>0.7
kIU/L) or positive skin prick test (wheal greater than 5 mm]), OR

2. Physician-supervised oral food challenge that elicited immediate allergic
symptoms, OR

3. Results of laboratory tests highly predictive of clinical reactivity to milk

- Serum milk IgE ≥15 [kIU/L]or ≥ 5 [kIU/L if younger than 1 year OR,

- Skin prick tests mean wheal >10 mm

4. Otherwise healthy

5. If subject has asthma, atopic dermatitis, and/or rhinitis, must be well controlled

6. Expected daily intake of at least 8 oz (240 ml) of the study formula during the open
challenge phase

7. Having obtained his/her legal representative's informed consent.

Exclusion Criteria:

1. Children consuming mother's milk at the time of inclusion and during the trial

2. Any chromosomal or major congenital anomalies

3. Any major gastrointestinal disease or abnormalities other than CMA

4. Chronic medical diseases (ie seizure disorders, chronic lung disease, heart problems
(heart murmurs acceptable)

5. Immunodeficiency

6. Receiving free amino acid formula

7. Anti-histamine use in 7 days prior to the first food challenge (eyedrops are
acceptable)

8. Oral steroid use within 14 days prior to enrollment (intranasal and topical
corticosteroids are okay)

9. Unstable asthma

10. Severe uncontrolled eczema

11. Recent ( within the last 3 months) severe anaphylactic reaction to milk

12. Subject who in the Investigator's assessment cannot be expected to adhere to the
study protocol

13. Currently participating in another clinical trial
We found this trial at
14
sites
Asheville, North Carolina 28801
?
mi
from
Asheville, NC
Click here to add this to my saved trials
Boerne, Texas 78006
?
mi
from
Boerne, TX
Click here to add this to my saved trials
Columbus, Georgia 31904
?
mi
from
Columbus, GA
Click here to add this to my saved trials
?
mi
from
Eagle, ID
Click here to add this to my saved trials
Edison, New Jersey 08817
?
mi
from
Edison, NJ
Click here to add this to my saved trials
Evansville, Indiana
?
mi
from
Evansville, IN
Click here to add this to my saved trials
Huntington Beach, California
?
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Little Rock, Arkansas
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Newburgh, New York 12550
?
mi
from
Newburgh, NY
Click here to add this to my saved trials
Richmond, Virginia
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Roseville, California 95678
?
mi
from
Roseville, CA
Click here to add this to my saved trials
Savannah, Georgia 31406
?
mi
from
Savannah, GA
Click here to add this to my saved trials
Vienna, Virginia 22180
?
mi
from
Vienna, VA
Click here to add this to my saved trials